載入...

Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC

BACKGROUND: Blood-based biomarkers of anti-solid tumor immune checkpoint blockade (ICB) response are lacking. We hypothesized that changes in systemic cytokine levels with the initial doses of programmed cell death protein 1 (PD-1) pathway inhibitors would correlate with clinical responses. New ultr...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Immunother Cancer
Main Authors: Keegan, Alissa, Ricciuti, Biagio, Garden, Padric, Cohen, Limor, Nishihara, Reiko, Adeni, Anika, Paweletz, Cloud, Supplee, Julianna, Jänne, Pasi A, Severgnini, Mariano, Awad, Mark M, Walt, David R
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537334/
https://ncbi.nlm.nih.gov/pubmed/33020238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000678
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!